Skip to main content
SpringerLink
Log in

Idiopathic Ventricular Fibrillation

  • Chapter
  • First Online:
Clinical Cardiogenetics

Abstract

Cardiac arrest (CA) mostly follows from cardiac disorders that elicit lethal ventricular tachyarrhythmias, primarily ventricular fibrillation (VF).

Funding: Netherlands Heart Foundation (grant 2005T024 to P.G.P); Fondation Leducq Trans-Atlantic Network of Excellence, Preventing Sudden Death (grant 05-CVD-01 to A.A.M.W.); ZorgOnderzoek Nederland Medische Wetenschappen (ZonMW, grant 120610013 to C.W.)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 209.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation. 1998;98:2334-2351.

    Article  PubMed  CAS  Google Scholar 

  2. Myerburg RJ, Castellanos A. Cardiac Arrest and Sudden Cardiac Death. In: Libby P, Bonow RO, Mann DL, Zipes DP, eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. Philadelphia, PA: Saunders Elsevier; 2008:933-973.

    Google Scholar 

  3. Chugh SS, Reinier K, Teodorescu C, et al. Epidemiology of sudden cardiac death: clinical and research implications. Prog Cardiovasc Dis. 2008;51:213-228.

    Article  PubMed  Google Scholar 

  4. Puranik R, Chow CK, Duflou JA, Kilborn MJ, McGuire MA. Sudden death in the young. Heart Rhythm. 2005;2:1277-1282.

    Article  PubMed  Google Scholar 

  5. Viskin S, Belhassen B. Idiopathic ventricular fibrillation. Am Heart J. 1990;120:661-671.

    Article  PubMed  CAS  Google Scholar 

  6. Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29:270-276.

    Article  PubMed  Google Scholar 

  7. Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol. 2003;42:1959-1963.

    Article  PubMed  Google Scholar 

  8. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009;119:1085-1092.

    Article  PubMed  Google Scholar 

  9. Hallstrom AP, Ornato JP, Weisfeldt M, et al. Public-access defibrillation and survival after out-of-hospital cardiac arrest. N Engl J Med. 2004;351:637-646.

    Article  PubMed  CAS  Google Scholar 

  10. Stiell IG, Wells GA, Field BJ, et al. Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: OPALS study phase II. Ontario Prehospital Advanced Life Support. JAMA. 1999;281:1175-1181.

    Article  PubMed  CAS  Google Scholar 

  11. Hollenberg J, Herlitz J, Lindqvist J, et al. Improved survival after out-of-hospital cardiac arrest is associated with an increase in proportion of emergency crew–witnessed cases and bystander cardiopulmonary resuscitation. Circulation. 2008;118:389-396.

    Article  PubMed  Google Scholar 

  12. Survivors of out-of-hospital cardiac arrest with apparently normal heart. Need for definition and standardized clinical evaluation. Consensus Statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States. Circulation 1997;95:265–72.

    Google Scholar 

  13. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med. 2001;345:1473-1482.

    Article  PubMed  CAS  Google Scholar 

  14. Chugh SS, Jui J, Gunson K, et al. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol. 2004;44:1268-1275.

    Article  PubMed  Google Scholar 

  15. Viskin S, Belhassen B. Clinical problem-solving. When you only live twice. N Engl J Med. 1995;332:1221-1225.

    Article  PubMed  CAS  Google Scholar 

  16. Viskin S. Brugada syndrome in children: don’t ask, don’t tell? Circulation. 2007;115:1970-1972.

    Article  PubMed  Google Scholar 

  17. Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol. 2008;52:1111-1121.

    Article  PubMed  Google Scholar 

  18. Wolpert C, Echternach C, Veltmann C, et al. Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome. Heart Rhythm. 2005;2:254-260.

    Article  PubMed  Google Scholar 

  19. Postema PG, Wolpert C, Amin AS et al. Drugs and Brugada syndrome patients: review of the literature, recommendations and an up-to-date website (www.brugadadrugs.org). Heart Rhythm 2009;9:1335-1341.

  20. Krahn AD, Gollob M, Yee R, et al. Diagnosis of unexplained cardiac arrest: role of adrenaline and procainamide infusion. Circulation. 2005;112:2228-2234.

    Article  PubMed  Google Scholar 

  21. Basso C, Calabrese F, Corrado D, Thiene G. Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings. Cardiovasc Res. 2001;50:290-300.

    Article  PubMed  CAS  Google Scholar 

  22. Tan HL, Hofman N, van Langen I, van der Wal AC, Wilde AA. Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation. 2005;112:207-213.

    Article  PubMed  Google Scholar 

  23. Behr E, Wood DA, Wright M, et al. Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome. Lancet. 2003;362:1457-1459.

    Article  PubMed  CAS  Google Scholar 

  24. Behr ER, Dalageorgou C, Christiansen M, et al. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur Heart J. 2008;29:1670-1680.

    Article  PubMed  Google Scholar 

  25. Haissaguerre M, Derval N, Sacher F, et al. Sudden cardiac arrest associated with early repolarization. N Engl J Med. 2008;358:2016-2023.

    Article  PubMed  CAS  Google Scholar 

  26. Klatsky AL, Oehm R, Cooper RA, Udaltsova N, Armstrong MA. The early repolarization normal variant electrocardiogram: correlates and consequences. Am J Med. 2003;115:171-177.

    Article  PubMed  Google Scholar 

  27. Mehta M, Jain AC, Mehta A. Early repolarization. Clin Cardiol. 1999;22:59-65.

    Article  PubMed  CAS  Google Scholar 

  28. Meissner FL. Taubstummheit und Taubstummenbildung: Beobachtungen und Erfahrungen. Leipzig/Heidelberg: C.F. Winter’sche Verslagehandlung; 1856:119-120.

    Google Scholar 

  29. Einthoven W. Ueber die Form des menschlichen Electrocardiogramms. Pflugers Arch Gesamte Physiol. 1895;60:101-123.

    Article  Google Scholar 

  30. Einthoven W. The different forms of the human electrocardiogram and their signification. Lancet. 1912;179:853-861.

    Article  Google Scholar 

  31. Edler I, Hertz CH. The use of the ultrasonic reflectoscope for the continuous recording of the movements of heart walls. Kungl Fysiogr Sällsk Lund Förhandl. 1954;24:1-19.

    Google Scholar 

  32. Watson JD, Crick FH. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature. 1953;171:737-738.

    Article  PubMed  CAS  Google Scholar 

  33. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860-921.

    Article  PubMed  CAS  Google Scholar 

  34. Maron BJ, Towbin JA, Thiene G et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006;113:1807–1816.

    Google Scholar 

  35. Lambiase PD, Elliott PM. Genetic aspects and investigation of sudden death in young people. Clin Med. 2008;8:607-610.

    Article  PubMed  Google Scholar 

  36. Haissaguerre M, Shoda M, Jais P, et al. Mapping and ablation of idiopathic ventricular fibrillation. Circulation. 2002;106:962-967.

    Article  PubMed  Google Scholar 

  37. Noda T, Shimizu W, Taguchi A, et al. Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract. J Am Coll Cardiol. 2005;46:1288-1294.

    Article  PubMed  Google Scholar 

  38. Alders M, Koopmann TT, Christiaans I, et al. Haplotype-sharing analysis implicates chromosome 7q36 harboring DPP6 in familial idiopathic ventricular fibrillation. Am J Hum Genet. 2009;84:468-476.

    Article  PubMed  CAS  Google Scholar 

  39. Radicke S, Cotella D, Graf EM, Ravens U, Wettwer E. Expression and function of dipeptidyl-aminopeptidase-like protein 6 as a putative beta-subunit of human cardiac transient outward current encoded by Kv4.3. J Physiol. 2005;565:751-756.

    Article  PubMed  CAS  Google Scholar 

  40. Leenhardt A, Glaser E, Burguera M, Nurnberg M, Maison-Blanche P, Coumel P. Short-coupled variant of torsade de pointes. A new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias. Circulation. 1994;89:206-215.

    Article  PubMed  CAS  Google Scholar 

  41. Haissaguerre M, Chatel S, Sacher F, et al. Ventricular Fibrillation with Prominent Early Repolarization Associated with a Rare Variant of KCNJ8/K Channel. J Cardiovasc Electrophysiol. 2009;20:93-98.

    Article  PubMed  Google Scholar 

  42. Akai J, Makita N, Sakurada H, et al. A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome. FEBS Lett. 2000;479:29-34.

    Article  PubMed  CAS  Google Scholar 

  43. Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 1980;303:322-324.

    Article  PubMed  CAS  Google Scholar 

  44. Wever EF, Hauer RN, Oomen A, Peters RH, Bakker PF, de Medina EO Robles. Unfavorable outcome in patients with primary electrical disease who survived an episode of ventricular fibrillation. Circulation. 1993;88:1021-1029.

    Article  PubMed  CAS  Google Scholar 

  45. Wever EF, de Medina EO Robles. Sudden death in patients without structural heart disease. J Am Coll Cardiol. 2004;43:1137-1144.

    Article  PubMed  Google Scholar 

  46. Coronel R, Casini S, Koopmann TT, et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. Circulation. 2005;112:2769-2777.

    Article  PubMed  Google Scholar 

  47. Brugada P, Brugada J, Brugada R. When our best is not enough: the death of a teenager with brugada syndrome. J Cardiovasc Electrophysiol. 2009;20:108-109.

    Article  PubMed  Google Scholar 

  48. Sherrid MV, Daubert JP. Risks and challenges of implantable cardioverter-defibrillators in young adults. Prog Cardiovasc Dis. 2008;51:237-263.

    Article  PubMed  Google Scholar 

  49. Sacher F, Probst V, Iesaka Y, et al. Outcome after implantation of a cardioverter-defibrillator in patients with brugada syndrome. A multicenter study. Circulation. 2006;114:2317-2324.

    Article  PubMed  Google Scholar 

  50. Viskin S, Halkin A. Treating the long-QT syndrome in the era of implantable defibrillators. Circulation. 2009;119:204-206.

    Article  PubMed  Google Scholar 

  51. Messali A, Thomas O, Chauvin M, Coumel P, Leenhardt A. Death due to an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol. 2004;15:953-956.

    Article  PubMed  Google Scholar 

  52. Viskin S, Wilde AA, Tan HL, Antzelevitch C, Shimizu W, Belhassen B. Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry. Heart Rhythm. 2009;6:401-404.

    Article  PubMed  Google Scholar 

  53. Kron J, Herre J, Renfroe EG, et al. Lead- and device-related complications in the antiarrhythmics versus implantable defibrillators trial. Am Heart J. 2001;141:92-98.

    Article  PubMed  CAS  Google Scholar 

  54. Raitt MH, Klein RC, Wyse DG, et al. Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Am J Cardiol. 2003;91:812-816.

    Article  PubMed  Google Scholar 

  55. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997;337:1576–1583.

    Google Scholar 

  56. Ayerza MR, de Zutter M, Goethals M, Wellens F, Geelen P, Brugada P. Heart transplantation as last resort against Brugada syndrome. J Cardiovasc Electrophysiol. 2002;13:943-944.

    Article  PubMed  Google Scholar 

  57. Belhassen B, Glick A, Viskin S. Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome. Pacing Clin Electrophysiol. 2009;32:294-301.

    Article  PubMed  Google Scholar 

  58. Belhassen B, Viskin S, Fish R, Glick A, Setbon I, Eldar M. Effects of electrophysiologic-guided therapy with Class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome. J Cardiovasc Electrophysiol. 1999;10:1301-1312.

    Article  PubMed  CAS  Google Scholar 

  59. Haissaguerre M, Sacher F, Nogami A, et al. Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. J Am Coll Cardiol. 2009;53:612-619.

    Article  PubMed  Google Scholar 

  60. Dock W. Transitory ventricular fibrillation as a cause of syncope and its prevention by quinidine sulphate: With case report and discussion of diagnostic criteria for ventricular fibrillation. Am Heart J. 1929;4:709-714.

    Article  Google Scholar 

  61. Moe T. Morgagni-Adams-Stokes attacks caused by transient recurrent ventricular fibrillation in a patient without apparent organic heart disease; a case report. Am Heart J. 1949;37:811-819.

    Article  PubMed  CAS  Google Scholar 

  62. Kontny F, Dale J. Self-terminating idiopathic ventricular fibrillation presenting as syncope: a 40-year follow-up report. J Intern Med. 1990;227:211-213.

    Article  PubMed  CAS  Google Scholar 

  63. Viskin S, Antzelevitch C, Marquez MF, Belhassen B. Quinidine: a valuable medication joins the list of ‘endangered species’. Europace. 2007;9:1105-1106.

    Article  PubMed  Google Scholar 

  64. Viskin S. Idiopathic ventricular fibrillation “Le Syndrome d’Haissaguerre” and the fear of J waves. J Am Coll Cardiol. 2009;53:620-622.

    Article  PubMed  Google Scholar 

  65. Wilde AA, Langendijk PN. Antiarrhythmic drugs, patients, and the pharmaceutical industry: value for patients, physicians, pharmacists or shareholders? Neth Heart J. 2007;15:127-128.

    Article  PubMed  CAS  Google Scholar 

  66. Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J. 1957;54:59-68.

    Article  PubMed  CAS  Google Scholar 

  67. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J. 1958;20:1-8.

    Article  PubMed  CAS  Google Scholar 

  68. Coumel P, Fidelle J, Lucet V, Attuel P, Bouvrain Y. Catecholamine-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: report of four cases. Br Heart J. 1978;40:28-37.

    Google Scholar 

  69. Marcus FI, Fontaine GH, Guiraudon G, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation. 1982;65:384-398.

    Article  PubMed  CAS  Google Scholar 

  70. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 1992;20:1391-1396.

    Article  PubMed  CAS  Google Scholar 

  71. Gussak I, Brugada P, Brugada J, et al. Idiopathic short QT interval: a new clinical syndrome? Cardiology. 2000;94:99-102.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Academic Medical Centre, Amsterdam, The Netherlands

    Pieter G. Postema

Authors
  1. Pieter G. Postema
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christian van der Werf
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arthur A. M. Wilde
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pieter G. Postema .

Editor information

Editors and Affiliations

  1. University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, 3508 GA, Netherlands

    H.F. Baars

  2. University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, 3508 GA, Netherlands

    P.A.F.M. Doevendans

  3. University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, 3508 GA, Netherlands

    J.J. van der Smagt

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag London Limited

About this chapter

Cite this chapter

Postema, P.G., van der Werf, C., Wilde, A.A.M. (2011). Idiopathic Ventricular Fibrillation. In: Baars, H., Doevendans, P., van der Smagt, J. (eds) Clinical Cardiogenetics. Springer, London. https://doi.org/10.1007/978-1-84996-471-5_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-84996-471-5_14

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84996-470-8

  • Online ISBN: 978-1-84996-471-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation